Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 50 min ago
Peer-reviewedCC BY 4.0Biomolecules

Glycosaminoglycan Recognition by YKL-40: Potential Regulation in Disease

  1. 1Genis, 580 Siglufjordur, Iceland
  2. 2School of Health, Business, and Natural Sciences, University of Akureyri, 600 Akureyri, Iceland
  3. 3School of Engineering and Natural Sciences, Science Institute, Department of Biochemistry, University of Iceland, 102 Reykjavik, Iceland

Abstract

YKL-40 (CHI3L1) is a secreted chitinase-like protein involved in inflammation, tissue remodeling, angiogenesis, and cancer. Although its biological activities have been extensively investigated, the molecular mechanisms regulating its extracellular interactions remain incompletely understood. YKL-40 binds several glycosaminoglycans (GAGs), including heparin (hep), heparan sulfate (HS), dermatan sulfate (DS), and hyaluronan (HA). YKL-40-GAG interactions are influenced by the GAG chain length, sulfation, and uronic acid composition, suggesting that YKL-40 selectively recognizes specific structural features of GAG chains rather than electrostatic interactions alone. YKL-40 is known to interact with the HS-containing cell-surface receptors CD44v3, syndecan-1, and syndecan-4, which have been implicated in YKL-40-mediated signaling associated with tumor progression and angiogenesis. Because HS structures are dynamically regulated through sulfation and the C5-epimerization of D-glucuronic acid (GlcA) to L-iduronic acid (IdoA), pathological remodeling may alter the binding properties of HS chains of these receptors. This hypothesis-driven review examines the structural determinants of YKL-40-GAG recognition and proposes a mechanism by which disease-associated changes in HS sulfation, the uronic acid composition, and motif organization could alter YKL-40 binding affinity for HS-containing receptors, potentially influencing their downstream signaling. However, whether such remodeling directly alters YKL-40 binding or signaling remains to be experimentally established. Understanding how receptor-associated HS structures influence YKL-40 recognition may provide new insights into its context-dependent biological activity and potential therapeutic targeting.

Related

  1. Dual Carbohydrate Recognition by the Chitinase-like Protein CHI3L1 Through Distinct Glycosaminoglycan and Chitin-Binding Interfaces
    O. Kurc, N. Rähse, M. Gopalswamy +4
    bioRxivPreprintCC BY-NC-NDFull textBiophysicsbioRxiv
  2. dsRNA: mechanisms of gene expression regulation, disease pathogenesis, and therapeutic potential
    Shuiping Liu, Chao Zhe, Jiyun Hou +10
    RNA BiologyPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationPMC
  3. Epigenetic Regulation of Pyroptosis in Kidney Disease: From Molecular Mechanisms to Therapeutic Potential
    Daoyu Sheng, Shanshan Han, Wenya Shang +1
    Journal of Inflammation ResearchPeer-reviewedCC BY-NC 4.0Full textMolecular biology & gene regulationPMC
  4. Bone-Directed Drug Delivery: From Mineral and Matrix Recognition to Cellular Regulation
    Raeyeong Kim, Daewon Jeong
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0General biochemistryCrossref
  5. Sialic Acids: From Biosynthesis and Molecular Recognition to Disease and Therapy
    Susan Bellis, Vladislav Panin
    Journal of Biological ChemistryPeer-reviewedCC BY 4.0Molecular biology & gene regulationCrossref
BibTeX
@article{magnusdottir2026glycosaminoglycan,
  title = {{Glycosaminoglycan Recognition by YKL-40: Potential Regulation in Disease}},
  author = {Unnur Magnusdottir and Kristinn R. Oskarsson and Jens G. Hjorleifsson and Jon M. Einarsson and Finnbogi R. Thormodsson},
  journal = {Biomolecules},
  year = {2026},
  month = nov,
  doi = {10.3390/biom16111659},
  url = {https://www.mdpi.com/2218-273X/16/11/1659},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Glycosaminoglycan Recognition by YKL-40: Potential Regulation in Disease
AU  - Unnur Magnusdottir
AU  - Kristinn R. Oskarsson
AU  - Jens G. Hjorleifsson
AU  - Jon M. Einarsson
AU  - Finnbogi R. Thormodsson
PY  - 2026
DA  - 2026/11/13
JO  - Biomolecules
DO  - 10.3390/biom16111659
UR  - https://www.mdpi.com/2218-273X/16/11/1659
AB  - YKL-40 (CHI3L1) is a secreted chitinase-like protein involved in inflammation, tissue remodeling, angiogenesis, and cancer. Although its biological activities have been extensively investigated, the molecular mechanisms regulating its extracellular interactions remain incompletely understood. YKL-40 binds several glycosaminoglycans (GAGs), including heparin (hep), heparan sulfate (HS), dermatan sulfate (DS), and hyaluronan (HA). YKL-40-GAG interactions are influenced by the GAG chain length, sulfation, and uronic acid composition, suggesting that YKL-40 selectively recognizes specific structural features of GAG chains rather than electrostatic interactions alone. YKL-40 is known to interact with the HS-containing cell-surface receptors CD44v3, syndecan-1, and syndecan-4, which have been implicated in YKL-40-mediated signaling associated with tumor progression and angiogenesis. Because HS structures are dynamically regulated through sulfation and the C5-epimerization of D-glucuronic acid (GlcA) to L-iduronic acid (IdoA), pathological remodeling may alter the binding properties of HS chains of these receptors. This hypothesis-driven review examines the structural determinants of YKL-40-GAG recognition and proposes a mechanism by which disease-associated changes in HS sulfation, the uronic acid composition, and motif organization could alter YKL-40 binding affinity for HS-containing receptors, potentially influencing their downstream signaling. However, whether such remodeling directly alters YKL-40 binding or signaling remains to be experimentally established. Understanding how receptor-associated HS structures influence YKL-40 recognition may provide new insights into its context-dependent biological activity and potential therapeutic targeting.
SN  - 2218-273X
ER  -